Personal information
Verified email addresses
Biography
Jesper B. Andersen received his Ph.D. in 2006 from the Department of Molecular and Structural Biology Aarhus University, Denmark, following a research fellowship (2003–2007) in the laboratory of Bret A. Hassel at the University of Maryland, Marlene and Stewart Greenebaum Cancer Center Baltimore, USA. From 2007 to 2014, he joined the laboratory of Snorri S. Thorgeirsson at the National Cancer Institute, National Institutes of Health (NIH) Maryland, USA. At NIH, he started a translational pharmacogenomics and epigenomics program focused on human hepatobiliary cancers. In 2014, he was appointed Associate Professor in translational research at Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences University of Copenhagen, Denmark. The main emphasis of his lab's current research is to understand molecular tumor heterogeneity as a cause of drug resistance, utilizing genome-wide approaches in modeling disease causality stratifying patients for advancing diagnostic and prognostic markers and therapy. He has published more than 50 seminal papers and book chapters, received several prestigious merit awards in cancer research, most recently from the Danish Cancer Society, 2015. His laboratory has received many competitive investigator awards/grants from the Novo Nordisk Foundation (Hallas-Møller), AP Møller Foundation, Lundbeck Foundation, Danish Cancer Society (Break Cancer), Medical Research Council for elite science in Denmark, and several Marie Sklodowska-Curie European Postdoc fellowships.